Pure Global AI
NCT06229652Not yet recruiting

Stress Management in Depressive Disorder: Resilience Training vs. Yoga: Biological, Epigenetic, and Brain Correlates

The Impact of Stress Management Interventions on Stress Perception, Coping Strategies, and Residual Symptoms in Depression: a Randomized Controlled Trial Investigating Psychological, Biological, Epigenetic, and Brain Correlates
Medical University InnsbruckClinicalTrials.govbehavioral
Verified
Study focus
Disease/Condition
Major Depressive Disorder
Drug/Device/Intervention
RASMUS Resilience Training
Study type
Interventional
Intervention type
behavioral
Sponsor & location
Primary sponsor
Medical University Innsbruck
Location
Innsbruck, Austria
Timeline & enrollment
Phase
N/A
Start date
Apr 01, 2024
End date
Apr 01, 2028
Enrollment
150 participants
Primary outcome

Total Change Scores on the Stress Processing Questionnaire (SVF-ak) among Study Completers,Total Change Scores on the Perceived Stress Scale (PSS-10) among Study Completers

Summary

The aim of this clinical trial is to evaluate the effects of a Resilience and Stress
 Management Intervention Program (RASMUS) compared with yoga on stress perception, coping
 strategies, depressive symptoms, anxiety, resilience and quality of life in people diagnosed
 with major depressive disorder (MDD) in the short and long term.
 
 In addition to psychological factors, biological parameters will be examined to define
 biomarkers involved in stress response. In the optional neuroimaging part, the effects of the
 planned interventions on the structure, metabolism and function of the brain will be
 investigated. The epigenetic part, which is also optional, will examine the effects of the
 planned interventions on the histone modifications.

ICD-10 classifications
Recurrent depressive disorderRecurrent depressive disorder, unspecifiedDepressive conduct disorderOther recurrent depressive disordersRecurrent depressive disorder, current episode moderate
Data source
Registry
ClinicalTrials.gov
Trial ID
NCT06229652
Type
Non-Device Trial
About this record

Access comprehensive clinical trial information for NCT06229652 through Pure Global AI's free database. This phase not specified trial is sponsored by Medical University Innsbruck and is currently Not yet recruiting. The study focuses on Major Depressive Disorder. Target enrollment is 150 participants.

This page provides complete trial specifications, intervention details, outcomes, and location information. Pure Global AI offers free access to ClinicalTrials.gov data, helping medical device and pharmaceutical companies navigate clinical research efficiently.